Skip to content

Clinical trials

Completed Phase 2/3 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2/3 Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20052
20062
20072
20084
20092
20112
20132
20143
20153
20161
20172
20181
20201
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Joslin Diabetes Center3
Universidad de Granada3
A.O.U. Città della Salute e della Scienza1
ARCA Biopharma, Inc.1
Ain Shams University1
Bambino Gesù Hospital and Research Institute1
Belfast Health and Social Care Trust1
Boston Medical Center1
Columbia University1
Coordinación de Investigación en Salud, Mexico1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation34
Metabolic Syndrome4
Diabetes Mellitus, Type 23
Heart Failure3
Obesity3
Overweight3
Asthma2
Atherosclerosis2
COVID-192
Diabetes Mellitus2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.